{"id":"American_Diabetes_Association_criteria_for_the_diagnosis_of_diabetes.v1.0-draft","gdl_version":"2.0","concept":"gt0001","language":{"original_language":"ISO_639-1::en"},"description":{"original_author":{"name":"Kevin Arjona","email":"kevin.arjona01@gmail.com","organisation":"Karolinska Insitutet"},"lifecycle_state":"Not set","details":{"en":{"id":"en","keywords":["ADA","Diabetes","DIabetes mellitus","Guideline"],"purpose":"Diagnosing diabetes based on the ADA's criteria.","use":"Used for diagnosing diabetes in adults based on the ADA's criteria.","misuse":"Do not use for diagnosis in patients with previous metabolic diseases affecting carbohydrate metabolism."}},"other_details":{"references":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021 [published correction appears in Diabetes Care. 2021 Sep;44(9):2182]. Diabetes Care. 2021;44(Suppl 1):S15-S33. doi:10.2337/dc21-S002"},"other_contributors":[]},"definition":{"data_bindings":{"gt0002":{"id":"gt0002","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_glucose.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test_glucose.v1","elements":{"gt0003":{"id":"gt0003","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078]"}}},"gt0005":{"id":"gt0005","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test-hba1c.v0","template_id":"openEHR-EHR-OBSERVATION.lab_test-hba1c.v0","elements":{"gt0007":{"id":"gt0007","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078]"}}},"gt0016":{"id":"gt0016","type":"OUTPUT","model_id":"openEHR-EHR-EVALUATION.problem_diagnosis.v1","template_id":"openEHR-EHR-EVALUATION.problem_diagnosis.v1","elements":{"gt0027":{"id":"gt0027","path":"/data[at0001]/items[at0002]"}}},"gt0020":{"id":"gt0020","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_glucose.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test_glucose.v1","elements":{"gt0022":{"id":"gt0022","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078]"}}},"gt0023":{"id":"gt0023","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_glucose.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test_glucose.v1","elements":{"gt0026":{"id":"gt0026","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078]"}}},"gt0028":{"id":"gt0028","type":"INPUT","model_id":"openEHR-EHR-CLUSTER.symptom.v1","template_id":"openEHR-EHR-CLUSTER.symptom.v1","elements":{"gt0029":{"id":"gt0029","path":"/items[at0035]"}}},"gt0030":{"id":"gt0030","type":"OUTPUT","model_id":"openEHR-EHR-EVALUATION.exclusion-problem_diagnosis.v1","template_id":"openEHR-EHR-EVALUATION.exclusion-problem_diagnosis.v1","elements":{"gt0031":{"id":"gt0031","path":"/data[at0001]/items[at0002.1]"}}}},"rules":{"gt0011":{"id":"gt0011","priority":1,"then":["$gt0027|Diagnosis of Diabetes mellitus| = 'Positive'"],"when":["$gt0003|Fasting glucose| >= 126,mg/dl"]},"gt0012":{"id":"gt0012","priority":2,"then":["$gt0027|Diagnosis of Diabetes mellitus| = 'Positive'","$gt0031|Observations| ="],"when":["$gt0007|HbA1c result| >= 6.5,%"]},"gt0015":{"id":"gt0015","priority":3,"then":["$gt0027|Diagnosis of Diabetes mellitus| = 'Positive'"],"when":["$gt0026|2-hour plasma glucose| >= 200,mg/dl"]},"gt0025":{"id":"gt0025","priority":4,"then":["$gt0027|Diagnosis of Diabetes mellitus| = 'Positive'"],"when":["$gt0003|Fasting glucose| >= 200,mg/dl","$gt0029|Symptoms of hyperglycemia or hyperglycemic crisis| == true"]},"gt0032":{"id":"gt0032","priority":5,"then":["$gt0031|Observations| ="],"when":["$gt0003|Fasting glucose| == null","$gt0007|Test HbA1c| == null","$gt0022|Random plasma glucose| == null","$gt0026|2-hour plasma glucose| == null","$gt0029|Symptoms of hyperglycemia or hyperglycemic crisis| == $gt0032|Null|"]}},"pre_conditions":[],"default_actions":["$gt0003|Fasting glucose| <= 125,mg/dl"]},"ontology":{"term_definitions":{"en":{"id":"en","terms":{"gt0001":{"id":"gt0001","text":"American Diabetes Association criteria for the diagnosis of diabetes","description":"The American Diabetes Association (ADA) \"Standards of Medical Care in Diabetes\" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care."},"gt0003":{"id":"gt0003","text":"Fasting glucose"},"gt0007":{"id":"gt0007","text":"Test HbA1c"},"gt0011":{"id":"gt0011","text":"Fasting glucose DM","description":"Hemoglobin A1C level ≥ 6.5%"},"gt0012":{"id":"gt0012","text":"HbA1C DM","description":"A1C ≥6.5%. The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay."},"gt0015":{"id":"gt0015","text":"2-hour plasma glucose DM","description":"2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an OGTT. The test should be performed as described by the World Health Organization, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water."},"gt0022":{"id":"gt0022","text":"Random plasma glucose"},"gt0025":{"id":"gt0025","text":"random plasma glucose DM","description":"In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥200 mg/dL (11.1 mmol/L)."},"gt0026":{"id":"gt0026","text":"2-hour plasma glucose"},"gt0027":{"id":"gt0027","text":"Diagnosis of Diabetes mellitus"},"gt0029":{"id":"gt0029","text":"Symptoms of hyperglycemia or hyperglycemic crisis"},"gt0031":{"id":"gt0031","text":"Observations"},"gt0032":{"id":"gt0032","text":"Null","description":"Missing data"}}},"es-mx":{"id":"es-mx","terms":{"gt0001":{"text":"Criterios de la Asociación Americana de Diabetes para el diagnóstico de diabetes","description":"Los \"Estándares de atención médica en diabetes\" de la Asociación Estadounidense de Diabetes (ADA) incluyen las recomendaciones de práctica clínica actuales de la ADA y tienen como objetivo proporcionar los componentes de la atención de la diabetes, objetivos y pautas generales de tratamiento, y herramientas para evaluar la calidad de la atención. ","id":"gt0001"},"gt0003":{"text":"Glucosa en ayuno","id":"gt0003"},"gt0007":{"text":" Resultado HbA1c ","id":"gt0007"},"gt0011":{"text":"Glucosa en ayuno en Diabetes mellitus","description":"Nivel de Hemoglobina A1C ≥ 6.5%","id":"gt0011"},"gt0012":{"text":"Niveles de HbA1C en Diabetes mellitus","description":"HbA1C ≥6,5%. La prueba debe realizarse en un laboratorio utilizando un método certificado por NGSP y estandarizado para el ensayo DCCT.","id":"gt0012"},"gt0015":{"text":"Curva de tolerancia a la glucosa de 2 horas","description":"Glucosa plasmática de 2 horas ≥200 mg/dL (11,1 mmol/L) durante una OGTT. La prueba debe realizarse según lo descrito por la Organización Mundial de la Salud, utilizando una carga de glucosa que contenga el equivalente a 75 g de glucosa anhidra disuelta en agua.","id":"gt0015"},"gt0022":{"text":"Prueba aleatoria de Glucosa plasmática","id":"gt0022"},"gt0025":{"text":"Prueba aleatoria de Glucosa plasmática","description":"En un paciente con síntomas clásicos de hiperglucemia o crisis hiperglucémica, una glucosa plasmática aleatoria ≥200 mg/dL (11,1 mmol/L).","id":"gt0025"},"gt0026":{"text":"Curva de tolerancia a la glucosa de 2 horas","id":"gt0026"},"gt0027":{"id":"gt0027","text":"*(en) Diabetes mellitus"},"gt0029":{"id":"gt0029","text":"*(en) Symptoms of hyperglycemia or hyperglycemic crisis"},"gt0031":{"id":"gt0031","text":"*(en) In the absence of unequivocal hyperglycemia, diagnosis requires 2 abnormal test results from the same sample or in 2 separate test samples"},"gt0032":{"id":"gt0032","text":"*(en) Null","description":"*(en) Missing data"}}}},"term_bindings":{}}}